A number of patients with advanced kidney cancer have been given new lives by the “target-free combination” therapy in Hainan Cancer Hospital

2022-05-18 0 By

Ms. Lin, who lives in Lingao, Hainan province, was diagnosed with advanced kidney cancer six months ago.After 5 courses of targeted drugs and immunotherapy, Ms. Lin was reexamined on February 14, and her physical indicators reached the standard of normal people.In July last year, 54-year-old Lin suffered from waist pain, dizziness and other symptoms, and was initially diagnosed as a “malignant tumor of the left kidney” at other hospitals in the province.Her family members accompanied Ms. Lin to a well-known hospital in Guangzhou for further treatment, and she was finally diagnosed as “advanced clear cell carcinoma of the left kidney accompanied by adrenal, thoracic, pelvic, cranial and systemic bone metastases”.Due to the loss of the best surgical treatment opportunity, experts recommend the use of targeted drugs and other “conservative treatment”.The urological team reviews the patient’s recovery.In late September last year, Ms. Lin’s condition deteriorated rapidly, with severe edema in her lower limbs and impaired heart and lung function.Ms Lin was rushed to the urology department of Hainan Cancer Hospital for treatment.”When she first arrived, Ms. Lin had a large amount of fluid in both sides of her chest, incontinence, inability to lie flat, and critical symptoms of cardiopulmonary failure.”Doctor Feng Huwen introduced that due to her serious condition, Ms. Lin was transferred to ICU for rescue and maintenance treatment.After intensive care, Ms. Lin’s condition was under control.Urology expert team carefully analyzed her condition, combined with previous experience, decided to use “target free combination” therapy for Ms. Lin treatment.Qu Jun of deputy director of urological department of surgery introduces, before kidney cancer conventional treatment is used commonly onoke target or immune cure method, the effect is not ideal.Since last year, combined with the latest international treatment guidelines, they have implemented targeted and immunodrug “combination therapy” for patients with intermediate and advanced renal cancer and other urinary malignancies that meet the treatment specifications, and achieved unexpected treatment results.Disclaimer: This article is reproduced for the purpose of conveying more information.If the source is wrong or violated your legitimate rights and interests, please contact the author with proof of ownership, we will promptly correct, delete, thank you.Email address: newmedia@xxcb.cn